News of Note—Astellas, Novavax and more

In this week's news of note, Astellas teamed up with ClearPath to work on a vaccine against S. aureus.

Here's some other vaccine news of note for the week:

> ClearPath and Astellas are teaming up to develop a Staphylococcus aureus vaccine. Release

> Novavax shares fell 22% as its updates this week in RSV and seasonal flu disappointed investors. Washington Business Journal article

> A Stanford team found a new way to combat Zika that could aid in drug and vaccine development. FierceBiotechResearch article

> PharmaJet and Invectys teamed up for a phase 2 study of cancer vaccine INVAC-1 using PharmaJet's needle-free vaccine technology. Release